Descriptive study of patients diagnosed of asthma in a regional respiratory medicine practice;Estudio descriptivo de los pacientes diagnosticados de asma en una consulta neumológica de ámbito comarcal

Archivos de Bronconeumologia

Volumn 35, Issue 4, 1999, Pages 167-172

  Pellicer, C ^a   Lorente, P ^a   Valero, P ^a   Cremades, M J ^a   Fullana, J ^a   Perpina M ^b   Gilabert, M J ^a   Garcia Peiro I ^a  

^a HOSPITAL FRANCESC DE BORJA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Bronchial asthma in general practice; Classification of bronchial asthma; Mild bronchial asthma

Indexed keywords

ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; ASTHMA; FEMALE; HUMAN; LUNG FUNCTION TEST; MALE; MIDDLE AGED; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; AGED; ALGORITHMS; ASTHMA; FEMALE; HUMANS; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS;

EID: 0033110220     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-2896(15)30273-8     Document Type: Article

References (32)

1. Woolcock AJ. Worldwide differences in asthma prevalence and mortality. Why is asthma mortality so low in the U.S.A.? Chest 1986; 90: 40-45.
2. Asher MI, Pattemore PK, Harrison AC, Mitchell EA, Rea HH, Stewart W et al. International comparison of the prevalence of asthma symptoms and bronchial hyperresponsiveness. Am Rev Respir Dis 1998; 136: 524-529.
3. Burney PGJ, Luczynska C, Chinn S, Jarvis D for the European Community Respiratory Health Survey. The European Community Respiratory Health Survey. Eur Respir J 1994; 7: 954-960.
4. Burney P, Chinn S, Jarvis D, Luczynska C, Lai E for the European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma, and use asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996; 9: 687-695.
5. Pearce N, Weiland S, Keil U, Landridge P, Anderson HR, Strachan et al. Self-reported prevalence of asthma symptoms in children in Australia, England,Germany and New Zealand: an international comparison using the ISAAC protocol. Eur Respir J 1993; 6: 1.455-1.461.
6. Grupo Español del Estudio Europeo del Asma. Estudio Europeo del Asma: Prevalencia de síntomas relacionados con el asma en cinco áreas españolas. Med Clin (Barc) 1995; 104: 487-492.
7. Rodríguez JA, Álvarez FJ, Segado A, Soto G, Capote F, Castillo J. Análisis de la prevalencia de sintomatología respiratoria en la población general. Arch Bronconeumol 1995; 31: 162-168.
8. Grupo Español del Estudio Europeo del Asma. Estudio Europeo del Asma. Prevalencia de hiperreactividad bronquial y asma en adultos jóvenes de cinco areas españolas. Med Clin (Barc) 1996; 106: 761-767.
9. Pellicer C, Fullana J, Cremades MJ, Rivera ML, Peripiñá M. Perfil de una consulta neumológica de ámbito comarcal. Arch Bronconeumol 1996; 32: 447-452.
10. Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yemault JC. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6 (Supl 16): 5-40.
11. Dekker FW, Schrier AC, Sterk PJ, Dijkman JM. Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction. Thorax 1992; 47: 162-166.
12. Quackenboss J, Lebowitz MD, Krzyzanowski M. Normal range of diurnal changes in expiratory flow rates. Relationship to symptoms and respiratory disease. Am Rev Respir Dis 1991; 143: 323-330.
13. Global Iniciative for Asthma. Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report. National Institutes of Health, Bethesda, Maland. Publication N.o 95-3659, 1995.
14. Chathman M, Bleecker ER, Normal PhL, Mason P. A screening test for airway reactivity. An abreviated methacholine inhalation challenge. Chest 1982; 82: 15-18.
15. Pellicer Ciscar C, Sanchis Aldas J. Prueba de provocación farmacológica bronquial. En: Perpiñá Tordera M, editor! Hiperreactividad bronquial inespecífica. Barcelona: Ediciones Doyma, 1993; 99-116.
16. Dreborg S. Skin test used in type I allergy testing. Allergy 1989; 44 (Supl 10): 22-31.
17. Roca J, Sanchis J, Agustí-Vidal A, Segarra F, Navajas D, Rodríguez-Roisín R et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 1986; 22: 217-224.
18. Barnes N. Treatment of mild asthma. Eur Respir Rev 1996; 6: 61-66.
19. Hahn DL, Beasley JW, and the Wisconsin Research Network (WReN) Asthma Prevalence Study Group. Diagnosed and possible undiagnosed asthma: a Wisconsin Research Network (WReN) Study. J Fam Pract 1994; 38: 373-379.
20. Larsson L, Boë Thius G, Uddenfeldt M. Differences in utilisation of asthma drugs between two neighbouring Swedish provinces: relation to prevalence of obstructive airway disease. Thorax 1994; 49: 41-49.
21. Meslier N, Racineux JL, Six P, Lockhart A. Diagnostic value of reversibility of chronic airway obstruction to separate asthma from bronchitis: a statistical approach. Eur Respir J 1989; 2: 497-505.
22. Popa V, Singleton J. Provocative dose and discriminant analysis in histamine bronchoprovocation; are the current predictive data satisfactory? Chest 1988; 94: 466-475.
23. Gilbert R, Auchincloss JH. Post-test probability of asthma following methacholine challenge. Chest 1990; 97: 562-565.
24. Pellicer Ciscar C, Perpiñá Tordera M, De Diego Damia A, Macián Gisbert V. Aportación del test broncodilatador al estudio de la reversibilidad bronquial. Arch Bronconeumol 1994; 30: 492-497.
25. Perpiñá M, Pellicer C, De Diego A, Compte L, Macián V. Diagnostic value of bronchial provocation test with methacholine in asthma. A Bayesian analysis approach. Chest 1994; 104: 149-156.
26. Banter TH, Pratter MR. Asthma: better outcome at lower cost? The role of the expert in the care system. Chest 1996; 110: 1.589-1.596.
27. O'Byrne PM. Treatment of mild asthma. Lancet 1997; 349: 818.
28. Rubinfeld AR, Pain CF. How mild is mild asthma? Thorax 1977; 32: 177-181.
29. Plaza V, Serra-Batlles J, Morejón E, Comella A, Brugués J. Características clínicas y morbilidad en el asma estable. Análisis descriptivo del asma en una comunidad mediterránea. Arch Bronconeumol 1997; 33: 457-461.
30. Cimas JE, Arce MC, González ME, López Viña A. Estudio de los factores relacionados con la morbilidad del asma. Arch Bronconeumol 1997; 33: 389-394.
31. Asthma Programme in Finland 1994-2004. Clin Exp Allergy 1996; 26 (Supl 1): 1-24.
32. Marks GB, Burney PGJ, Premaratne UN, Simpson J, Webb J. Asthma in Greenwich, UK: impact of the disease and current management practices. Eur Respir J 1997; 10: 1.224-1.229.